Ledger.Open graph →
SEC Form D · filed June 3, 2022

Kera Therapeutics, Inc

Offering
—
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MEDFIELD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jiagang Zhao · Medfield, MADirectorReza Dana · Medfield, MADirectorJason Werner · Medfield, MAExec · DirectorDavid Neafus · Medfield, MAExecBrad Osborne · Brentwood, TNDirectorRick Farnell · Boise, IDDirectorNick Efstratis · Boise, IDExec · DirectorGeorge Mulhern · Boise, IDExecRobert J. Short · Polson, MTDirectorChris Popp · New York, NYExecMike Tobin · New York, NYDirectorJean-Bastien Auger · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗